Two doses of zoster vaccine reduce risk for herpes zoster ophthalmicus

Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute myocardial infarction, and stroke among adults aged 50 years or older, according to a study published online Aug. 9 in Clinical Infectious Diseases.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup